Chinese stocks finished higher on Monday following a blockbuster showing in the country's trade and a loosening of capital rules for insurers and brokers.
The Shanghai Composite Index, the main gauge of Chinese stocks, gained 0.6% or 21.27 points to reach 3,924.08. The Shenzhen Component Index rose 1.4% or by 182.31 points to 13,329.99.
The country logged a trade surplus of $1.12 trillion in November after exports jumped 5.9% year over year, Customs said Monday.
This marks the first time China's surplus topped $1 trillion, Bloomberg said separately.
China's National Financial Regulatory Administration loosened the factors for multiple businesses of insurance companies, Xinhua News Agency reported Friday.
The financial regulator said the adjustments will help encourage long-term investments to support the capital market, the report said.
Among the adjustments are the removal of risk factors for stock holdings and insurers, the report said.
The CSI Investment Banking and Brokerage Index gained 2% at market close, while the insurance index inched up 1%. Ping An's (SHA:601318) Shanghai shares gained 2% during the close of trading Monday.
Jiangsu Aidea Pharmaceutical (SHA:688488) closed 3% higher after it renewed its two anti-immunodeficiency virus drugs, ainuoweilin and ainoumiti, on China's 2025 national reimbursement drug list.
Comments